We have shown that lung cancers in LSL-Kras; Ink4a/ARFFL/FL mice maintain the ability to induce the p53 transcriptional target p21 and to activate the G1 cell-cycle arrest. The gene discussed is KRAS; the disease is lung carcinoma.